Identification of potentially irritating intravenous medications

AIMSTo identify commonly used intravenous drugs that may produce endothelial damage. METHODSAn experimental research study was performed using a sample of 62 intravenous drugs commonly used in emergency care, pH and osmolarity were measured. Subsequently, based on these values, the theoretical capac...

Full description

Saved in:
Bibliographic Details
Published inEnfermería Intensiva (English ed.) Vol. 33; no. 3; pp. 132 - 140
Main Authors Ballesteros-Peña, S., Fernández-Aedo, I., Vallejo-De la Hoz, G., Tønnesen, J., Miguelez, C.
Format Journal Article
LanguageEnglish
Published 01.07.2022
Online AccessGet full text

Cover

Loading…
Abstract AIMSTo identify commonly used intravenous drugs that may produce endothelial damage. METHODSAn experimental research study was performed using a sample of 62 intravenous drugs commonly used in emergency care, pH and osmolarity were measured. Subsequently, based on these values, the theoretical capacity to cause irritation or endovascular damage was determined and classified as high, moderate, and low. RESULTSSamples from 19 drugs for fluid therapy, 21 antibiotics and 22 drugs for intravenous use were studied. Glucose solutions, sodium bicarbonate 1M and mannitol 10% showed a high capacity to cause venous irritation. Vancomycin, ciprofloxacin, amiodarone, haloperidol, and labetalol solution presented a high capacity for irritation based on their acidic pH. The antibiotics, dexketoprofen, diazepam, digoxin, etomidate, phenytoin, levetiracetam and metamizole also showed high osmotic values in their reconstituted or undiluted presentations. Moreover, osmolarity of diazepam, digoxin and phenytoin remained high despite being diluted in 100 ml of saline. CONCLUSIONSKnowing the pH and osmolarity of intravenous drugs allows their capacity to cause endothelial damage to be assessed. The use of comprehensive tables based on the chemical properties of the drugs can be a useful tool to help prevent chemically-induced phlebitis.
AbstractList AIMSTo identify commonly used intravenous drugs that may produce endothelial damage. METHODSAn experimental research study was performed using a sample of 62 intravenous drugs commonly used in emergency care, pH and osmolarity were measured. Subsequently, based on these values, the theoretical capacity to cause irritation or endovascular damage was determined and classified as high, moderate, and low. RESULTSSamples from 19 drugs for fluid therapy, 21 antibiotics and 22 drugs for intravenous use were studied. Glucose solutions, sodium bicarbonate 1M and mannitol 10% showed a high capacity to cause venous irritation. Vancomycin, ciprofloxacin, amiodarone, haloperidol, and labetalol solution presented a high capacity for irritation based on their acidic pH. The antibiotics, dexketoprofen, diazepam, digoxin, etomidate, phenytoin, levetiracetam and metamizole also showed high osmotic values in their reconstituted or undiluted presentations. Moreover, osmolarity of diazepam, digoxin and phenytoin remained high despite being diluted in 100 ml of saline. CONCLUSIONSKnowing the pH and osmolarity of intravenous drugs allows their capacity to cause endothelial damage to be assessed. The use of comprehensive tables based on the chemical properties of the drugs can be a useful tool to help prevent chemically-induced phlebitis.
Author Fernández-Aedo, I.
Miguelez, C.
Ballesteros-Peña, S.
Tønnesen, J.
Vallejo-De la Hoz, G.
Author_xml – sequence: 1
  givenname: S.
  surname: Ballesteros-Peña
  fullname: Ballesteros-Peña, S.
– sequence: 2
  givenname: I.
  surname: Fernández-Aedo
  fullname: Fernández-Aedo, I.
– sequence: 3
  givenname: G.
  surname: Vallejo-De la Hoz
  fullname: Vallejo-De la Hoz, G.
– sequence: 4
  givenname: J.
  surname: Tønnesen
  fullname: Tønnesen, J.
– sequence: 5
  givenname: C.
  surname: Miguelez
  fullname: Miguelez, C.
BookMark eNpNkDFPwzAQhS1UJErpL2DJyJJwduzE3kAVlEqVWGC2XOeCXCV2sFOk_ntS2oHpTnfvnd59t2Tmg0dC7ikUFGj1uC_Qtw4LBowWIAqA8orMmWAqV5LD7F9_Q5Yp7QGACVXVrJ6Tp02DfnSts2Z0wWehzYYwnkam646Zi9GN08Z_Zc6P0fygD4eU9dhcDOmOXLemS7i81AX5fH35WL3l2_f1ZvW8zS2VlOc1RSWBGsPVTlHLQRljleWspcKYqpZCMZTSGmYbLBVFAVI0gu8a2XCxq8sFeTjfHWL4PmAade-Sxa4zHqdImtXT35RXik_S8iy1MaQUsdVDdL2JR01Bn5Dpvf5Dpk_INAg9WctfzjFjCg
CitedBy_id crossref_primary_10_3390_antibiotics12081338
crossref_primary_10_3389_fmed_2022_1037274
Cites_doi 10.1007/s40268-020-00329-w
10.1097/NAN.0000000000000081
10.1177/1129729819877323
10.1086/674398
10.7764/Horiz_Enferm.22.2.37
10.1038/s41598-018-21617-1
10.1097/00000446-200302000-00027
10.2131/jts.24.113
10.2146/ajhp161028
10.4103/jfmpc.jfmpc_559_19
10.4037/ccn2019381
10.1097/00152193-199811000-00021
10.1111/jocn.14760
10.1590/0104-1169.0192.2603
10.7326/0003-4819-114-10-845
ContentType Journal Article
DBID AAYXX
CITATION
7X8
DOI 10.1016/j.enfie.2021.05.003
DatabaseName CrossRef
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2529-9840
EndPage 140
ExternalDocumentID 10_1016_j_enfie_2021_05_003
GroupedDBID --M
0R~
AACTN
AAEDT
AAEDW
AAKOC
AALRI
AAOAW
AAXUO
AAYXX
ABMAC
ACDAQ
ACGFS
ACRLP
ADBBV
AEBSH
AFJKZ
AFTJW
AFXIZ
AGUBO
AIEXJ
AIKHN
AITUG
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AXJTR
BNPGV
CITATION
EBS
EFJIC
EJD
FDB
FIRID
KOM
M41
O9-
ROL
SNG
SSH
SSZ
T5K
~G-
7X8
ID FETCH-LOGICAL-c1814-71e9801aa49b91c409aac9c42f15aa678592e88ca2cde391e5085d54bd8d45b73
ISSN 2529-9840
IngestDate Sat Aug 17 02:21:29 EDT 2024
Thu Sep 26 16:31:59 EDT 2024
IsPeerReviewed false
IsScholarly true
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1814-71e9801aa49b91c409aac9c42f15aa678592e88ca2cde391e5085d54bd8d45b73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PQID 2700314694
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_2700314694
crossref_primary_10_1016_j_enfie_2021_05_003
PublicationCentury 2000
PublicationDate 2022-07-00
20220701
PublicationDateYYYYMMDD 2022-07-01
PublicationDate_xml – month: 07
  year: 2022
  text: 2022-07-00
PublicationDecade 2020
PublicationTitle Enfermería Intensiva (English ed.)
PublicationYear 2022
References Garate (10.1016/j.enfie.2021.05.003_bib0060) 2015
Manrique-Rodríguez (10.1016/j.enfie.2021.05.003_bib0045) 2021; 21
Plan Nacional de Resistencia a Antibióticos (10.1016/j.enfie.2021.05.003_bib0055) 2019
Aizpuru Martínez (10.1016/j.enfie.2021.05.003_bib0035) 2021
Gorski (10.1016/j.enfie.2021.05.003_bib0085) 2015; 38
Stranz (10.1016/j.enfie.2021.05.003_bib0095) 2005
Maklin (10.1016/j.enfie.2021.05.003_bib0120) 2003; 103
10.1016/j.enfie.2021.05.003_bib0115
Mandal (10.1016/j.enfie.2021.05.003_bib0020) 2019; 8
Maki (10.1016/j.enfie.2021.05.003_bib0105) 1991; 114
Wallis (10.1016/j.enfie.2021.05.003_bib0010) 2014; 35
Nicotera (10.1016/j.enfie.2021.05.003_bib0065) 2011; 30
Oragano (10.1016/j.enfie.2021.05.003_bib0070) 2019; 39
Lv (10.1016/j.enfie.2021.05.003_bib0005) 2020; 21
Simin (10.1016/j.enfie.2021.05.003_bib0015) 2019; 28
Pérez Melgarejo (10.1016/j.enfie.2021.05.003_bib0050) 2011; 22
Piper (10.1016/j.enfie.2021.05.003_bib0110) 2018; 8
Registered Nurses Association of Ontario (10.1016/j.enfie.2021.05.003_bib0025) 2004
Stranz (10.1016/j.enfie.2021.05.003_bib0100) 2002; 6
Meng (10.1016/j.enfie.2021.05.003_bib0080) 2018; 75
Kokotis (10.1016/j.enfie.2021.05.003_bib0040) 1998; 28
Milutinović (10.1016/j.enfie.2021.05.003_bib0030) 2015; 23
Bruniera (10.1016/j.enfie.2021.05.003_bib0075) 2015; 19
Kuwahara (10.1016/j.enfie.2021.05.003_bib0090) 1999; 24
References_xml – year: 2004
  ident: 10.1016/j.enfie.2021.05.003_bib0025
  contributor:
    fullname: Registered Nurses Association of Ontario
– volume: 30
  start-page: 34
  year: 2011
  ident: 10.1016/j.enfie.2021.05.003_bib0065
  article-title: La flebite associata alla terapia endovenosa/infusionale [Phlebitis associated to intravenous/infusional therapy]
  publication-title: Assist Inferm Ric
  contributor:
    fullname: Nicotera
– volume: 21
  start-page: 39
  year: 2021
  ident: 10.1016/j.enfie.2021.05.003_bib0045
  article-title: Standardization and chemical characterization of intravenous therapy in adult patients: a step further in medication safety
  publication-title: Drugs R D
  doi: 10.1007/s40268-020-00329-w
  contributor:
    fullname: Manrique-Rodríguez
– volume: 38
  start-page: 27
  year: 2015
  ident: 10.1016/j.enfie.2021.05.003_bib0085
  article-title: Intermittently delivered IV medication and pH: reevaluating the evidence
  publication-title: J Infus Nurs
  doi: 10.1097/NAN.0000000000000081
  contributor:
    fullname: Gorski
– volume: 21
  start-page: 342
  year: 2020
  ident: 10.1016/j.enfie.2021.05.003_bib0005
  article-title: The incidence and risk of infusion phlebitis with peripheral intravenous catheters: a meta-analysis
  publication-title: J Vasc Access
  doi: 10.1177/1129729819877323
  contributor:
    fullname: Lv
– volume: 35
  start-page: 63
  year: 2014
  ident: 10.1016/j.enfie.2021.05.003_bib0010
  article-title: Risk factors for peripheral intravenous catheter failure: a multivariate analysis of data from a randomized controlled trial
  publication-title: Infect Control Hosp Epidemiol
  doi: 10.1086/674398
  contributor:
    fullname: Wallis
– volume: 22
  start-page: 37
  year: 2011
  ident: 10.1016/j.enfie.2021.05.003_bib0050
  article-title: Flebitis postinfusión en catéteres venosos periféricos: una actualización del arte
  publication-title: Horiz Enferm
  doi: 10.7764/Horiz_Enferm.22.2.37
  contributor:
    fullname: Pérez Melgarejo
– volume: 8
  start-page: 3441
  year: 2018
  ident: 10.1016/j.enfie.2021.05.003_bib0110
  article-title: The mechanistic causes of peripheral intravenous catheter failure based on a parametric computational study
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-21617-1
  contributor:
    fullname: Piper
– year: 2015
  ident: 10.1016/j.enfie.2021.05.003_bib0060
  contributor:
    fullname: Garate
– volume: 103
  start-page: 55
  year: 2003
  ident: 10.1016/j.enfie.2021.05.003_bib0120
  article-title: Phlebitis
  publication-title: Am J Nurs
  doi: 10.1097/00000446-200302000-00027
  contributor:
    fullname: Maklin
– volume: 24
  start-page: 113
  year: 1999
  ident: 10.1016/j.enfie.2021.05.003_bib0090
  article-title: Experimental infusion phlebitis: tolerance pH of peripheral veins
  publication-title: J Toxicol Sci
  doi: 10.2131/jts.24.113
  contributor:
    fullname: Kuwahara
– volume: 75
  start-page: 284
  year: 2018
  ident: 10.1016/j.enfie.2021.05.003_bib0080
  article-title: Association between continuous peripheral i.v. infusion of 3% sodium chloride injection and phlebitis in adults
  publication-title: Am J Health Syst Pharm
  doi: 10.2146/ajhp161028
  contributor:
    fullname: Meng
– ident: 10.1016/j.enfie.2021.05.003_bib0115
– volume: 8
  start-page: 2827
  year: 2019
  ident: 10.1016/j.enfie.2021.05.003_bib0020
  article-title: Study on incidence of phlebitis following the use of pherpheral intravenous catheter
  publication-title: J Family Med Prim Care
  doi: 10.4103/jfmpc.jfmpc_559_19
  contributor:
    fullname: Mandal
– year: 2021
  ident: 10.1016/j.enfie.2021.05.003_bib0035
  contributor:
    fullname: Aizpuru Martínez
– start-page: 1
  year: 2005
  ident: 10.1016/j.enfie.2021.05.003_bib0095
  article-title: The implications of osmolality, osmolarity and pH in infusion therapy
  publication-title: INS Annual Conference
  contributor:
    fullname: Stranz
– volume: 39
  start-page: e1
  year: 2019
  ident: 10.1016/j.enfie.2021.05.003_bib0070
  article-title: Phlebitis in intravenous amiodarone administration: incidence and contributing factors
  publication-title: Crit Care Nurse
  doi: 10.4037/ccn2019381
  contributor:
    fullname: Oragano
– volume: 28
  start-page: 41
  year: 1998
  ident: 10.1016/j.enfie.2021.05.003_bib0040
  article-title: Preventing chemical phlebitis
  publication-title: Nursing
  doi: 10.1097/00152193-199811000-00021
  contributor:
    fullname: Kokotis
– year: 2019
  ident: 10.1016/j.enfie.2021.05.003_bib0055
  contributor:
    fullname: Plan Nacional de Resistencia a Antibióticos
– volume: 28
  start-page: 1585
  year: 2019
  ident: 10.1016/j.enfie.2021.05.003_bib0015
  article-title: Incidence, severity and risk factors of peripheral intravenous cannula-induced complications: an observational prospective study
  publication-title: J Clin Nurs
  doi: 10.1111/jocn.14760
  contributor:
    fullname: Simin
– volume: 23
  start-page: 677
  year: 2015
  ident: 10.1016/j.enfie.2021.05.003_bib0030
  article-title: Fatores de risco para flebite: estudo com questionário sobre a percepção dos enfermeiros
  publication-title: Rev Lat Am
  doi: 10.1590/0104-1169.0192.2603
  contributor:
    fullname: Milutinović
– volume: 19
  start-page: 694
  year: 2015
  ident: 10.1016/j.enfie.2021.05.003_bib0075
  article-title: The use of vancomycin with its therapeutic and adverse effects: a review
  publication-title: Eur Rev Med Pharmacol Sci
  contributor:
    fullname: Bruniera
– volume: 114
  start-page: 845
  year: 1991
  ident: 10.1016/j.enfie.2021.05.003_bib0105
  article-title: Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-114-10-845
  contributor:
    fullname: Maki
– volume: 6
  start-page: 216
  year: 2002
  ident: 10.1016/j.enfie.2021.05.003_bib0100
  article-title: A review of pH and Osmolarity
  publication-title: Int J Pharm Compd
  contributor:
    fullname: Stranz
SSID ssj0002596727
Score 2.235149
Snippet AIMSTo identify commonly used intravenous drugs that may produce endothelial damage. METHODSAn experimental research study was performed using a sample of 62...
SourceID proquest
crossref
SourceType Aggregation Database
StartPage 132
Title Identification of potentially irritating intravenous medications
URI https://search.proquest.com/docview/2700314694
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZWrYS4oPISbWkVJG4hUeLYu_GNLS1sQa2Q2KLeIjuZSF0tCVrSA_wifmbHj2S9tEKUSxR5k9EmMxl__uZhQl7nCSDuAIikkipi1UREeV6iM-T5BFcPshqbKv6z8_Hsgn285Jej0W8va-m6U3H56866kv_RKo6hXnWV7D00OwjFATxH_eIRNYzHf9KxrbKtHe1mkpfbTg_J5fJneLVamQbcpmil09sMmXasJpru8XQ9La8r_765yPmxDPvcdqkxqCv2DaGKPergSO_DohsttD-iz6BvPEoNFv0S-zS1kZhqrjqaQmWo2dPhgq9axqKNjiFcynDWGj77w_Dz3EjNG71Ppq0iiX2egq5zWp07o5yKSOS2OVMMd4w5f2wbYzi7yzznmjom1M7Tqb3r1hRg2YhFDE19pfug0tS0Zk2y9YzXR_n_mAiH9MQ-821RGCGFFlIkvDBtZbcpujT0pdvT00-z84HPw2WkDmrrvQz7h-qbXJl0wlt_ZxMIbeIAA27mO-SRW5UEU2tij8kImifkwZnLu3hK3m5aWtDWgWdpwdrSAs_SAs_SnpGL9yfzd7PI7b0RlYj5dIouCAQvUjKhRFqyREhZipLROuVSIsLhggJ-1ZKWFWQiBQT6vOJMVXnFuJpkz8lW0zbwggT1BAAoXs2VZEqOFa3qPGE1ZIqqTGW75E3_IorvtsVK8RcN7JJX_csq0BXq-JZsAJ-q0DkUGc78gu3dT-Q-ebi22Jdkq1tdwwFizU4dOjXfAOjOfCA
link.rule.ids 315,783,787,27936,27937
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+potentially+irritating+intravenous+medications&rft.jtitle=Enfermer%C3%ADa+Intensiva+%28English+ed.%29&rft.au=Ballesteros-Pe%C3%B1a%2C+S.&rft.au=Fern%C3%A1ndez-Aedo%2C+I.&rft.au=Vallejo-De+la+Hoz%2C+G.&rft.au=T%C3%B8nnesen%2C+J.&rft.date=2022-07-01&rft.issn=2529-9840&rft.eissn=2529-9840&rft.volume=33&rft.issue=3&rft.spage=132&rft.epage=140&rft_id=info:doi/10.1016%2Fj.enfie.2021.05.003&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_enfie_2021_05_003
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2529-9840&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2529-9840&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2529-9840&client=summon